Clinical trial
D-Serine vs Placebo for the Schizophrenia Prodrome
NCT00826202 is registered in ClinicalTrials.gov with Nathan Kline Institute for Psychiatric Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- D-Serine vs Placebo for the Schizophrenia Prodrome
- Lead sponsor
- Nathan Kline Institute for Psychiatric Research
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- November 30, 2012
- Enrollment
- 44 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
schizophrenia prodrome